A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men

Arch Dermatol. 2012 Feb;148(2):257-9. doi: 10.1001/archdermatol.2011.1406.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Cidofovir
  • Cytosine / administration & dosage
  • Cytosine / adverse effects
  • Cytosine / analogs & derivatives*
  • Cytosine / therapeutic use
  • Double-Blind Method
  • Facial Dermatoses / drug therapy*
  • Folliculitis / drug therapy
  • Hair Diseases / drug therapy*
  • Humans
  • Male
  • Organophosphonates / administration & dosage
  • Organophosphonates / adverse effects
  • Organophosphonates / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Organophosphonates
  • Cytosine
  • Cidofovir